Laurion Capital Management’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.56M | Sell |
3,316,626
-52,622
| -2% | -$120K | 0.14% | 25 |
|
|
2025
Q1 | $5.22M | Buy |
3,369,248
+179,701
| +6% | +$279K | 0.13% | 38 |
|
|
2024
Q4 | $7.5M | Hold |
3,189,547
| – | – | 0.14% | 37 |
|
|
2024
Q3 | $11.6M | Sell |
3,189,547
-456,683
| -13% | -$1.66M | 0.16% | 24 |
|
|
2024
Q2 | $12.7M | Buy |
3,646,230
+1,555,759
| +74% | +$5.41M | 0.15% | 45 |
|
|
2024
Q1 | $13.3M | Buy |
2,090,471
+1,205,000
| +136% | +$7.69M | 0.11% | 69 |
|
|
2023
Q4 | $5.7M | Sell |
885,471
-590,635
| -40% | -$3.8M | 0.05% | 73 |
|
|
2023
Q3 | $3.44M | Sell |
1,476,106
-23,894
| -2% | -$55.7K | 0.02% | 101 |
|
|
2023
Q2 | $3.57M | Hold |
1,500,000
| – | – | 0.02% | 75 |
|
|
2023
Q1 | $2.76M | Hold |
1,500,000
| – | – | 0.02% | 93 |
|
|
2022
Q4 | $2.85M | Buy |
+1,500,000
| New | +$2.85M | 0.01% | 99 |
|
|
2021
Q2 | – | Sell |
-152,847
| Closed | -$876K | – | 484 |
|
|
2021
Q1 | $876K | Buy |
+152,847
| New | +$876K | ﹤0.01% | 314 |
|
|
2020
Q3 | – | Sell |
-67,519
| Closed | -$1.08M | – | 622 |
|
|
2020
Q2 | $1.08M | Sell |
67,519
-51,215
| -43% | -$821K | 0.01% | 206 |
|
|
2020
Q1 | $711K | Buy |
+118,734
| New | +$711K | 0.01% | 302 |
|
|
2019
Q3 | – | Sell |
-45,314
| Closed | -$730K | – | 586 |
|
|
2019
Q2 | $730K | Buy |
+45,314
| New | +$730K | 0.01% | 319 |
|
|
2018
Q4 | – | Sell |
-24,190
| Closed | -$730K | – | 698 |
|
|
2018
Q3 | $730K | Sell |
24,190
-50,810
| -68% | -$1.53M | 0.01% | 380 |
|
|
2018
Q2 | $2.01M | Buy |
+75,000
| New | +$2.01M | 0.02% | 368 |
|